Press Release Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results Aug 6
Press Release Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 4